Skip to main content

Advertisement

SpringerLink
Log in

HPV Vaccination Completion and Compliance with Recommended Dosing Intervals Among Female and Male Adolescents in an Inner-City Community Health Center

  • Original Paper
  • Published:
Journal of Community Health Aims and scope Submit manuscript

Abstract

Human papillomavirus (HPV) vaccination continues to lag behind other adolescent vaccines, especially in areas with pervasive disparities in HPV-related cancers. The purpose of this study was to examine HPV vaccine completion and dosing intervals among low-income adolescents in urban areas. The study included electronic health record data on HPV vaccination for 872 adolescents who received at least one dose of the HPV vaccine. Only 28.4 % completed the 3-dose series. For the whole sample, HPV vaccine completion was higher for non-English speakers and among adolescents seen at Newark-South and East Orange sites. Completion was higher among non-English speaking female and Hispanic adolescents, females seen in Newark-South and East Orange sites, and insured Black adolescents. Completion was also dramatically lower among non-English speaking Black adolescents seen at Newark-North, Irvington, and Orange sites (12.5 %) compared to other Black adolescents (22.0–44.4 %). The mean dosing intervals were 5.5 months (SD = 4.6) between dose 1 and 2 and 10 months (SD = 6.1) between dose 1 and 3. Longer durations between vaccine doses were found among uninsured adolescents and those seen at Newark-North, Irvington, and Orange sites. Non-English speakers had longer duration between dose 1 and 3. Further, durations between dose 1 and 3 were dramatically longer among insured adolescents seen at Newark-North, Irvington, and Orange locations for the whole sample (M = 11.70; SD = 7.12) and among Hispanic adolescents (M = 13.45; SD = 8.54). Understanding how the study predictors facilitate or impede HPV vaccination is critical to reducing disparities in cervical and other HPV-related cancer, especially among Black, Hispanic, and low-income populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Centers for Disease Control and Prevention. (2012). Human papillomavirus-associated cancers: United States, 2004–2008. MMWR. Morbidity and Mortality Weekly Report, 61, 258–261.

    Google Scholar 

  2. US Cancer Statistics Working Group. United States Cancer Statistics: 1999–2007 Incidence and mortality web-based report. Available at: www.cdc.gov/uscs.

  3. Benard, V. B., Johnson, C. J., Thompson, T. D., et al. (2008). Examining the association between socioeconomic status and potential human papillomavirus-associated cancers. Cancer, 113, 2910–2918.

    Article  PubMed  Google Scholar 

  4. US Cancer Statistics Working Group. United States Cancer Statistics: 2006–2010, cervical cancer ranked by state. Available at: http://apps.nccd.cdc.gov/uscs/cancersrankedbystate.aspx#text.

  5. Roche, L. M., Niu, X., & Henry, K. A. (2014). Invasive cervical cancer disparities in New Jersey. Presented at the 2014 Annual Retreat on Cancer Research in New Jersey, Piscataway, NJ (May 21, 2014).

  6. Markowitz, L. E., Hariri, S., Lin, C., et al. (2013). Reduction in Human Papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010. Journal of Infectious Diseases, 208, 385–393.

    Article  CAS  PubMed  Google Scholar 

  7. Niccolai, L. M., Julian, P. J., Meek, J. I., et al. (2013). Declining rates of high-grade cervical lesions in young women in Connecticut, 2008–2011. Cancer Epidemiology, Biomarkers and Prevention, 22, 1446–1450.

    Article  PubMed  Google Scholar 

  8. Elam-Evans, L. D., Yankey, D., Jeyarajah, J., et al. (2014). National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2013. MMWR. Morbidity and Mortality Weekly Report, 63, 625–633.

    PubMed  Google Scholar 

  9. Bastani, R., Glenn, B. A., Tsui, J., et al. (2011). Understanding suboptimal Human Papillomavirus vaccine uptake among ethnic minority girls. Cancer Epidemiology Biomarkers & Prevention, 20, 1463–1472.

    Article  Google Scholar 

  10. Manhart, L. E., Burgess-Hull, A. J., Fleming, C. B., et al. (2011). HPV vaccination among a community sample of young adult women. Vaccine, 29, 5238–5244.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Rubin, R., Kuttab, H.-M., Rihani, R., et al. (2012). Patient adherence to three dose completion of the Quadrivalent Human Papillomavirus (HPV) vaccine in a private practice. Journal of Community Health, 37, 1145–1150.

    Article  PubMed  Google Scholar 

  12. Reiter, P. L., McRee, A. L., Pepper, J. K., et al. (2013). Longitudinal predictors of human papillomavirus vaccination among a national sample of adolescent males. American Journal of Public Health, 103, 1419–1427.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Hirth, J. M., Tan, A., Wilkinson, G. S., et al. (2013). Completion of the human papillomavirus (HPV) vaccine series among males with private insurance between 2006 and 2009. Vaccine, 31, 1138–1140.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Centers for Disease Control and Prevention. (2011). National and state vaccination coverage among adolescents aged 13 through 17 years–United States, 2010. MMWR. Morbidity and Mortality Weekly Report, 60, 1117–1123.

    Google Scholar 

  15. Centers for Disease Control and Prevention. (2012). National and state vaccination coverage among adolescents aged 13–17 years–United States, 2011. MMWR. Morbidity and Mortality Weekly Report, 61, 671–677.

    Google Scholar 

  16. Centers for Disease Control and Prevention. (2013). National and state vaccination coverage among adolescents aged 13–17 years–United States, 2012. MMWR. Morbidity and Mortality Weekly Report, 62, 685–693.

    Google Scholar 

  17. Cook, R. L., Zhang, J., Mullins, J., et al. (2010). Factors associated with unitiation and completion of Human Papillomavirus vaccine series among young women enrolled in Medicaid. The Journal of Adolescent Health, 47, 596–599.

    Article  PubMed  Google Scholar 

  18. Widdice, L. E., Bernstein, D. I., Leonard, A. C., et al. (2011). Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics, 127, 77–84.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Chao, C., Velicer, C., Slezak, J. M., et al. (2010). Correlates for Human Papillomavirus vaccination of adolescent girls and young women in a managed care organization. American Journal of Epidemiology, 171, 357–367.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Keenan, K., Hipwell, A., & Stepp, S. (2012). Race and sexual behavior predict uptake of the human papillomavirus vaccine. Health Psychology, 31, 31–34.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Perkins, R. B., Brogly, S. B., Adams, W. G., et al. (2012). Correlates of human papillomavirus vaccination rates in low-income, minority adolescents: A multicenter study. Journal of Women’s Health (Larchmt), 21, 813–820.

    Article  Google Scholar 

  22. Gilkey, M. B., Moss, J. L., McRee, A.-L., et al. (2012). Do correlates of HPV vaccine initiation differ between adolescent boys and girls? Vaccine, 30, 5928–5934.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Staras, S. A. S., Vadaparampil, S. T., Haderxhanaj, L. T., et al. (2010). Disparities in Human Papillomavirus vaccine series initiation among adolescent girls enrolled in Florida Medicaid programs, 2006–2008. The Journal of Adolescent Health, 47, 381–388.

    Article  PubMed Central  PubMed  Google Scholar 

  24. Sadigh, G., Dempsey, A. F., Ruffin, Mt, et al. (2012). National patterns in human papillomavirus vaccination: An analysis of the National Survey of Family Growth. Human Vaccines & Immunotherapeutics, 8, 234–242.

    Article  Google Scholar 

  25. Chando, S., Tiro, J. A., Harris, T. R., et al. (2013). Effects of socioeconomic status and health care access on low levels of human papillomavirus vaccination among Spanish-speaking Hispanics in California. American Journal of Public Health, 103, 270–272.

    Article  PubMed Central  PubMed  Google Scholar 

  26. Tiro, J. A., Tsui, J., Bauer, H. M., et al. (2012). Human papillomavirus vaccine use among adolescent girls and young adult women: An analysis of the 2007 California Health Interview Survey. Journal of Women’s Health (Larchmt), 21, 656–665.

    Article  Google Scholar 

  27. Lau, M., Lin, H., & Flores, G. (2012). Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of Children’s Health. Vaccine, 30, 3112–3118.

    Article  PubMed  Google Scholar 

  28. Hirth, J. M., Tan, A., Wilkinson, G. S., et al. (2012). Completion of the human papillomavirus vaccine series among insured females between 2006 and 2009. Cancer, 118, 5623–5629.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Gold, R., Naleway, A., & Riedlinger, K. (2013). Factors predicting completion of the human papillomavirus vaccine series. The Journal of Adolescent Health, 52, 427–432.

    Article  PubMed  Google Scholar 

  30. Centers for Disease Control and Prevention. (2014). HPV vaccine. Available at http://www.cdc.gov/hpv/vaccine.html.

  31. Dorell, C. G., Stokley, S., Yankey, D., et al. (2012). Compliance with recommended dosing intervals for HPV vaccination among females, 13–17 years, National Immunization Survey-Teen, 2008–2009. Vaccine, 30, 503–505.

    Article  PubMed  Google Scholar 

  32. Tan, W., Viera, A. J., Rowe-West, B., et al. (2011). The HPV vaccine: Are dosing recommendations being followed? Vaccine, 29, 2548–2554.

    Article  PubMed  Google Scholar 

  33. Wilson, R. M., Brown, D. R., & Carmody, D. P. (2014). Prevalence and correlates of HPV vaccine initiation among low-income adolescents. Poster presentation at NIH/NIMH’s 2014 International Symposium on Minority Health and Health Disparities, Washington, DC (Dec 1, 2014).

  34. Agresti, A., & Finlay, B. (2009). Statistical methods for the social sciences (4th ed.). Upper Saddle River, NJ: Prentice Hall.

    Google Scholar 

  35. Reiter, P. L., McRee, A. L., Kadis, J. A., et al. (2011). HPV vaccine and adolescent males. Vaccine, 29, 5595–5602.

    Article  PubMed Central  PubMed  Google Scholar 

  36. Han, C. S., Ferris, D. G., Waller, J., et al. (2012). Comparison of knowledge and attitudes toward human papillomavirus, HPV vaccine, pap tests, and cervical cancer between US and Peruvian women. Journal of Lower Genital Tract Disease, 16, 121–126.

    Article  PubMed  Google Scholar 

  37. Cui, Y., Baldwin, S. B., Wiley, D. J., et al. (2010). Human Papillomavirus vaccine among adult women: Disparities in awareness and acceptance. American Journal of Preventive Medicine, 39, 559–563.

    Article  PubMed  Google Scholar 

  38. Marlow, L. A. V., Wardle, J., Forster, A. S., et al. (2009). Ethnic differences in human papillomavirus awareness and vaccine acceptability. Journal of Epidemiology and Community Health, 63, 1010–1015.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  39. Schluterman, N. H., Terplan, M., Lydecker, A. D., et al. (2011). Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital. Vaccine, 29, 3767–3772.

    Article  PubMed  Google Scholar 

  40. Pourat, N., & Jones, J. M. (2012). Role of insurance, income, and affordability in human papillomavirus vaccination. The American Journal of Managed Care, 18, 320–330.

    PubMed  Google Scholar 

  41. Moss, J. L., Gilkey, M. B., Reiter, P. L., et al. (2012). Trends in HPV vaccine initiation among adolescent females in North Carolina, 2008–2010. Cancer Epidemiology, Biomarkers and Prevention, 21, 1913–1922.

    Article  PubMed Central  PubMed  Google Scholar 

  42. Darden, P. M., Thompson, D. M., Roberts, J. R., et al. (2013). Reasons for not vaccinating adolescents: National Immunization Survey of Teens, 2008–2010. Pediatrics.

  43. Schmidt, S., & Parsons, H. M. (2014). Vaccination interest and trends in Human Papillomavirus vaccine uptake in young adult women aged 18–26 years in the United States: An analysis using the 2008–2012 National Health Interview Survey. American Journal of Public Health pp. e1–e8.

  44. US Department of Health and Human Services. Healthy people 2020. Washington, DC: US Department of Health and Human Services; 2012. Available at http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=23; 2012.

  45. President’s Cancer Panel (PCP). Accelerating HPV vaccine uptake: Urgency for Action to Prevent Cancer. A Report to the President of the United States from the President’s Cancer Panel.

  46. Frieden, T. Five Things I’ll Track Closely in 2014: The vaccine too few are getting: We’ve got to increase uptake of the HPV vaccine—it’s an anti-cancer vaccine. Available at http://www.huffingtonpost.com/tom-frieden-md-mph/cdcs-top-ten-five-for-201_b_4465682.html.

Download references

Author information

Authors and Affiliations

  1. Rutgers School of Nursing, 65 Bergen St., Newark, NJ, 07101, USA

    Rula M. Wilson & Dennis P. Carmody

  2. Rutgers School of Public Health, 65 Bergen St., Newark, NJ, 071012, USA

    Diane R. Brown & Sushanna Fogarty

Authors
  1. Rula M. Wilson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Diane R. Brown
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dennis P. Carmody
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sushanna Fogarty
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rula M. Wilson.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wilson, R.M., Brown, D.R., Carmody, D.P. et al. HPV Vaccination Completion and Compliance with Recommended Dosing Intervals Among Female and Male Adolescents in an Inner-City Community Health Center. J Community Health 40, 395–403 (2015). https://doi.org/10.1007/s10900-014-9950-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10900-014-9950-7

Keywords

Search

Navigation